Rainbow children: It may be beneficial to leave the Rainbow Children’s Medicare list, get clarification on growing

Post-Covid, it may become difficult for RCML to achieve a similar level of profit in FY23.

Synopsis

Rainbow Children’s Medicare (RCML), supported by the CDC, is a chain of multi-specialty pediatric, obstetrics and gynecology hospitals in India. The company is launching a ₹1,581 crore initial public offering comprising a new issue and a sale offering in which the UK government’s development finance institution CDC, along with developers, are part-opting out.

ET Intelligence Group: Rainbow Children’s Medicare (RCML), supported by the CDC, is a chain of multi-specialty pediatric, obstetrics and gynecology hospitals in India. The company is launching a ₹1,581 crore initial public offering comprising a new issue and a sale offering in which the UK government’s development finance institution CDC, along with developers, are part-opting out. The proceeds of the new issue will be allocated to the early redemption of

  • GIFT ITEM
  • FONT SIZE
  • TO SAFEGUARD
  • TO PRINT
  • COMMENT

Why ?

  • Exclusive Economic Times stories, editorials and expert opinions in more than 20 sectors

  • Stock analysis. Market research. Industry trends on more than 4000 actions

  • own experience with
    Minimal Ads

  • Comment and engage with the ET Prime community

  • Exclusive invitations to Virtual events with industry leaders

  • A trusted team of Journalists and analysts who can best filter the signal from the noise

Comments are closed.